Login
Toggle navigation
Videos
Categories
Trending
Andrew Wilkinson, co-founder of Tiny Capital and WeCommerce, discussed WeCommerce's recent trading debut on CNBC with Scott Wapner.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jordan Taub is the CEO of WeCommerce Holdings.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Maximizing Fleet Efficiency: EROAD & Phillips Connect Partnership Webinar Highlights | David Kenneson, Co-Chief Executive Officer of EROAD Ltd
00:10:00
Insights from Gordon Bajnai: Chairman of Campbell Lutyens' Global Advisory Board on Private Equity and Investment Trends at IPEM 2019
00:10:00
Strategic Financing and Exploration Plans: A Conversation with North Isle Copper and Gold
00:10:00
Ian Heslop, Head of Global Equities, Old Mutual Investors: Insights on Absolute Return Strategies
00:10:00
Shanshui Cement in China Is in Default | Li Heping, CEO, China Shanshui Cement Group LtdCCGLF:PKC
00:10:00
Michael B. Coleman and Jeffrey W. Edwards Inducted into Central Ohio Business Hall of Fame | Jeffrey W. Edwards - President, CEO and Chairman of Installed Building Products
00:10:00
"At Belden, regardless of career stage, thrive in an environment fostering support, continuous professional growth, and exploration of potential."|David Aldrich is Director and Chair of the Board of Belden Inc
00:10:00
Partnering with Tech Professionals: Strategic Financial Planning with SeedSafe Financial | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Exploring Tanzania's Gold Frontier: A Conversation with Dr. Ray Skipper, CEO of Endany Gold Inc.
00:10:00
Evolution and Triumphs in the Nordic Tech Arena: A Decade of Innovation and Global Impact | Tellef Thorleifsson, CEO, Norfund.
00:10:00
Andreas Gerward of Stayble Therapeutics on Treatment Methods and Anticipated Q4'24 Data | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
As projections remain high for the economic performance of the Philippines, Mr. Kevin Andrew Tan, Chief Executive Officer (CEO) of the Alliance Global Group, Inc., remains optimistic about the nation's growth prospects.|Kevin Andrew L.Tan currently works